Skip to content

VirAdvice

Active Private limited companyfounded 2011active for 14 yearsHeidebergstraat 278, 3010 LeuvenKBO/BCE: BE 0841.456.687

Lifetime

14 annual accounts with figures on one time axis
peak of €45,906 in 2012
€16,927▲ 7.7%
lowest -€1,838 in 2020
€10,292▲ 12.8%
peak of €69,432 in 2025
€69,432▲ 11.2%
€5,660▼ 52.9%
Board3 names since 2011
2 directors and 1 other
Documentsfilings and deeds
30-06-202631 days before the deadline
2025micro format
Dividend €3,281Debts from €12,027 to €5,660

Key points

from the 2025 annual accounts

Equity

€69,432 ▲ 11.2%
62,4212024+10,292Profit-3,281Dividend69,4322025

VirAdvice paid out €3,281 in dividends. That is 32% of the 2025 profit.

Liquidity

6.39 was 2.86 in 2024

Short-term debts fell from €12,027 to €5,660.

Filings

14 annual accounts since 2012
AprilJune31 JulyOctober201520202025

Six of the last ten came late. The 2019 accounts came in latest, 88 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,726 companies had the same profile as VirAdvice has now. Each dot stands for 87 companies, two years later.

95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,726 companies, not a prediction for VirAdvice. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0841456687
Company renamed from to VirAdvice changes role from manager to statutory director · appointed as director · Director discharge: Johan Neyts (manager) · General meeting of 25-02-2022 · Gazette deed
Incorporation Founded by · Founding capital of €18,600, 100 shares, €12,400 paid up · appointed as statutory manager · published on 13-12-2011 · Gazette deed
First establishment , Heidebergstraat 278, Leuven
All 26 events

Comparable companies

same main activity, similar in size and age
Company
VirAdvice Leuven €75,092 €16,927 92.5% -
EUROPEAN SCIENTIFIC LEAGUE FOR PROBIOTICS-LIGUE SCIENTIFIQUE EUROPEENNE DES PROBIOTIQUES-EUROPESE WETENSCHAPPELIJKE LIGA VOOR PROBIOTICA Genappe €65,899 €8,866 16.4% -
Docteur Vincent HEINEN pneumologie Juprelle €50,087 €10,267 59.2% -
OXYLENT Ath €97,758 €6,052 19.0% -
Synthesites Uccle €128,948 €20,168 38.7% -
GD-EMF-Consulting Hasselt €155,595 €18,157 87.9% -
Société Médicale Dr VAN DURME Liège €121,781 €35,012 76.6% -

These companies have the same main activity as VirAdvice: other research and development on natural sciences (NACE 72109). They are comparable in size and age: total assets between €50,100 and €156,000, founded between 2009 and 2015.

Official details

Source: KBO
Status
Active since 25-11-2011Normal situation
Activity
Other research and development on natural sciencesNACE 72109and 2 others
Establishment unit
2.205.230.4643010 Leuven, since 25-11-2011
Financial year end
31 December
Peppol
Reachable since 18-02-2026
Company details

Annual accounts 2025

≈ €130,000estimated
€75,092▲ 0.9%
Filing
Filed on 30-06-2026, 31 days before the end of the filing period
Financials

Insights on VirAdvice

VirAdvice files the micro format. That format states no turnover. The gross margin fell from €45,906 in 2012 to €16,927 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about VirAdvice

What is the company number of VirAdvice?
The company number of VirAdvice is 0841.456.687. The VAT number is the same number with BE in front: BE 0841.456.687.
Where is VirAdvice based?
The registered office is at Heidebergstraat 278, 3010 Leuven.Company details
What does VirAdvice do?
According to the KBO register, the main activity is other research and development on natural sciences (NACE 72109).
What is the legal form of VirAdvice?
VirAdvice is a private limited company (BV).
When was VirAdvice founded?
VirAdvice was founded on 25-11-2011.
Is VirAdvice still active?
Yes, VirAdvice is an active enterprise in the KBO register.
What is the turnover of VirAdvice?
The turnover in financial year 2025 is ≈ €130,000. This figure is estimated from the gross margin of €16,927 and 7,101 comparable companies of the same size. It probably lies between €57,000 and €300,000. It is a rough estimate.Financials
Is VirAdvice profitable?
In financial year 2025, VirAdvice made a profit of €10,292.
Where can I find the annual accounts of VirAdvice?
VirAdvice filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of VirAdvice due?
VirAdvice must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.